ANIX
NASDAQ
$3.46
Anixa Biosciences Inc (ANIX)
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $10 (+189.02%)
Market Cap
$119M
Free Cash Flow Yield
-5.99%
Beta (5Y)
1.30
Price Chart
Valuation
Market Cap$119M
P/S377.78
P/B7.47
Profitability
EBITDA-$10M
EPS-$0.30
Financial Health
Free Cash Flow Yield-5.99%
Growth & Risk
EPS 5Y CAGR-3.53%
FCF 5Y CAGR+6.82%
Beta (5Y)1.30
Sharpe Ratio0.35